دورية أكاديمية

Oral administration of herbal oligonucleotide drug JGL-sRNA-h7 ameliorates hyperglycemia in db/db mice and beagle dogs.

التفاصيل البيبلوغرافية
العنوان: Oral administration of herbal oligonucleotide drug JGL-sRNA-h7 ameliorates hyperglycemia in db/db mice and beagle dogs.
المؤلفون: Tang, Kegong, Wang, Xiaona, Jiang, Zhenyu, Chen, Mingrui, Deng, Xingyu, Mei, Song, Ma, Yiming, Du, Xinyi, Guo, Shaoting, Lin, Yexuan, Dong, Yixin, Liu, Dengyuan, Xu, Longxin, Jiang, Chengyu
المصدر: IUBMB Life ; ISSN:1521-6551
بيانات النشر: Wiley
سنة النشر: 2024
المجموعة: PubMed Central (PMC)
مصطلحات موضوعية: hyperglycemia, oligonucleotide drug, oral administration
الوصف: Type 2 diabetes mellitus is a prevalent metabolic disease, posing a considerable threat to public health. Oligonucleotide drugs have proven to be a promising field of therapy for the diseases. In this study, we reported that a herbal small RNA (sRNA), JGL-sRNA-h7 (B34735529, F1439.L002444.A11), could exhibit potent hypoglycemic effects by targeting glucose-6-phosphatase. Oral administration of sphingosine (d18:1)-JGL-sRNA-h7 bencaosomes ameliorated hyperglycemia and diabetic kidney injury better than metformin in db/db mice. Furthermore, glucose tolerance was also improved in sphingosine (d18:1)-JGL-sRNA-h7 bencaosomes-treated beagle dogs. Our study indicates that JGL-sRNA-h7 could be a promising hypoglycemic oligonucleotide drug.
نوع الوثيقة: article in journal/newspaper
اللغة: English
العلاقة: https://doi.org/10.1002/iub.2859Test; https://pubmed.ncbi.nlm.nih.gov/38935610Test
DOI: 10.1002/iub.2859
الإتاحة: https://doi.org/10.1002/iub.2859Test
https://pubmed.ncbi.nlm.nih.gov/38935610Test
حقوق: © 2024 International Union of Biochemistry and Molecular Biology.
رقم الانضمام: edsbas.B696B259
قاعدة البيانات: BASE